Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

Blood (2021) 138 (Supplement 1): 262.

https://doi.org/10.1182/blood-2021-147709

Published: 2021

Journal Articles

Donor Lymphocyte Infusion for Primary Cutaneous T Cell Lymphomas: A Study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the French Study Group on Cutaneous Lymphomas (GFLEC)

Blood (2018) 132 (Supplement 1): 3341.

https://doi.org/10.1182/blood-2018-99-119566

Published: 2018

Journal Articles

Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study

Florent Malard, Myriam Labopin, Ibrahim Yakoub-Agha, Sylvain Chantepie, Thierry Guillaume, Didier Blaise, Reza Tabrizi, Leonardo Magro, Bernard Vanhove, Gilles Blancho, Philippe Moreau, Béatrice Gaugler, Patrice Chevallier, Mohamad Mohty

Blood (2017) 130 (20): 2186–2195.

https://doi.org/10.1182/blood-2017-05-786137

Published: 2017

Includes: Supplemental data

Journal Articles

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Thierry Guillaume, MD PhD, Ibrahim Yakoub-Agha, MD- PhD, Reza Tabrizi, MD, Cecile Borel, MD, Patrice Chevallier, MD PhD, Leonardo Magro, MD, Stéphane Vigouroux, MD, Pierre Peterlin, MD, Alice Garnier, MD, Marie-Thérèse Rubio, MD PhD, Anne Huynh, MD, Noel Milpied, MD PhD, Philippe Moreau, Mohamad Mohty, MD PhD

Blood (2016) 128 (22): 1162.

https://doi.org/10.1182/blood.V128.22.1162.1162

Published: 2016

Journal Articles

Pretransplant Plasmatic Citrulline and Monocyte-Derived Macrophage Reactivity : Two Useful Surrogate Markers to Predict Acute GvHD

Thomas Hueso, MD, Leonardo Magro, MD, Marie Jonquel-chevalier Curt, PhD, Ibrahim Yakoub-Agha, MD- PhD, David Seguy, MD- PhD

Blood (2016) 128 (22): 4592.

https://doi.org/10.1182/blood.V128.22.4592.4592

Published: 2016

Journal Articles

Plasma Citrulline Level As a Biochemical Marker to Predict and Diagnose Graft-Versus-Host Disease

Benjamin Carpentier, MD, Remy Dulery, MD, David Seguy, MD, David Beauvais, MD, Arthur Simonnet, MD, Jordan Gauthier, MD, Valérie Coiteux, MD, Leonardo Magro, MD, Ibrahim Yakoubagha, MD

Blood (2014) 124 (21): 3931.

https://doi.org/10.1182/blood.V124.21.3931.3931

Published: 2014

Journal Articles

Ileostomy As a Treatment Option in Patients with Refractory Acute Gastro-Intestinal Graft Versus Host Disease

Stéphanie Guidez, Valerie Coiteux, MD, Romain Gerard, MD, Remy Dulery, MD, Leonardo Magro, MD, Ibrahim Yakoub-Agha, MD PhD, Alain Saudemont, MD, David Seguy, MD

Blood (2014) 124 (21): 5869.

https://doi.org/10.1182/blood.V124.21.5869.5869

Published: 2014

Journal Articles

Monitoring of Wilms’ Tumor 1 Expression As Minimal Residual Disease in Patients with Acute Myeloid Leukemia to Predict Relapse before and after Allogeneic Stem Cell Transplantation

Remy Dulery, MD, Olivier Nibourel, PhD, Vincent Elsermans, David Beauvais, MD, Arthur Simonnet, MD, Jordan Gauthier, MD, Valérie Coiteux, MD, Leonardo Magro, MD, Bruno Quesnel, MD, Claude Preudhomme, Ibrahim Yakoub-Agha, MD PhD

Blood (2014) 124 (21): 1265.

https://doi.org/10.1182/blood.V124.21.1265.1265

Published: 2014

Journal Articles

Long-Term Follow-Up Of Invasive Aspergillosis In Allogeneic Stem Cell Transplantation Recipients and Leukemia Patients: Differences In Risk Factors and Outcoumes

Sarah Bonnet, MD, Remy Dulery, MD, Khalid Regany, MD, Serge Alfandari, MD, Malek Bouketouche, MD, Zoé Van de Wyngaert, MD, Benjamin Carpentier, MD, Jordan Gauthier, MD, Leonardo Magro, MD, Céline Berthon, MD, PhD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2013) 122 (21): 4568.

https://doi.org/10.1182/blood.V122.21.4568.4568

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation From Unrelated One-Antigen HLA-Mismatched Donor, Increases Acute II-IV Gvhd Incidence without Interfering with Other Post-Transplant Complications

Eva De Berranger, Louis Terriou, Valérie Coiteux, Leonardo Magro, Françoise Dufossé, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2010) 116 (21): 2378.

https://doi.org/10.1182/blood.V116.21.2378.2378

Published: 2010

Journal Articles

Nilotinib as Salvage Therapy In Patients with Chronic Graft Versus Host Disease

Louis Terriou, Leonardo Magro, Eva De Berranger, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2010) 116 (21): 2329.

https://doi.org/10.1182/blood.V116.21.2329.2329

Published: 2010

Journal Articles

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease

Leonardo Magro, Mohamad Mohty, Benoit Catteau, Valérie Coiteux, Patrice Chevallier, Louis Terriou, Jean-Pierre Jouet, Ibrahim Yakoub-Agha

Blood (2009) 114 (3): 719–722.

https://doi.org/10.1182/blood-2009-02-204750

Published: 2009

Journal Articles

Improvement of Supportive Care in Patients Undergoing Myeloablative Allogeneic Stem Cell Transplantation Not Only Reduces Transplant-Related Mortality but Also Increases Long-Term Survival

Benedicte Bruno, MD, David Seguy, MD, Vincent Maunoury, MD, PhD, Valerie Coiteux, MD, Leonardo Magro, MD, Francis Bauters, MD, Francoise Mazingue, MD, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD

Blood (2008) 112 (11): 4318.

https://doi.org/10.1182/blood.V112.11.4318.4318

Published: 2008

Journal Articles

Immune Reconstitution Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28 neg CD8 + T-Cells on Relapse.

Ibrahim Yakoub-Agha, MD, PhD, Pasquine Saule, Julia Salleron, Pascale Cracco, Valerie Coiteux, Leonardo Magro, Francoise Dufosse, Benedicte Bruno, Jean-Pierre Jouet, Alain Duhamel, Jean-Paul Dessaint, Myriam Labalette

Blood (2008) 112 (11): 1146.

https://doi.org/10.1182/blood.V112.11.1146.1146

Published: 2008

Journal Articles

Pre-Transplant Bone Status Evaluation in Patients Undergoing Allogeneic Stem Cell Transplantation.

Ibrahim Yakoub-Agha, MD, PhD, Cecile Wibaux, Leonardo Magro, Audrey Juilliard, Isabelle Legroux-Gerot, Valerie Coiteux, Jean-Pierre Jouet, Bernard Cortet

Blood (2008) 112 (11): 2131.

https://doi.org/10.1182/blood.V112.11.2131.2131

Published: 2008

Journal Articles

Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease.

Ibrahim YakoubAgha, MD, PhD, Leonardo Magro, MD, Benoit Catteau, MD, Christophe Willekens, Valerie Coiteux, MD, Benedicte Bruno, MD, Louis Terriou, Jean-Pierre Jouet, MD

Blood (2008) 112 (11): 2141.

https://doi.org/10.1182/blood.V112.11.2141.2141

Published: 2008

Journal Articles

Proportions of T-Cell CD8+ Subsets Lacking CD28 Expression at Day 30 after Myeloablative Allogeneic Stem Cell Transplantation Are Predictive for Relapse and Chronic GVHD.

Ibrahim Yakoub-Agha, MD, PhD, Pasquine Saule, Leonardo Magro, Pascale Cracco, Valerie Coiteux, Benedicte Bruno, Manuel Cliquennois, Francoise Dufosse, Jean-Pierre Jouet, Jean-Paul Dessaint, Myriam Labalette

Blood (2007) 110 (11): 2979.

https://doi.org/10.1182/blood.V110.11.2979.2979

Published: 2007

Journal Articles

Efficacy of a low dose of thalidomide in advanced multiple myeloma

Xavier Leleu, Leonardo Magro, Abir Fawaz, Francis Bauters, Tierry Facon, Ibrahim Yakoub-Agha

Blood (2002) 100 (4): 1519.

https://doi.org/10.1182/blood-2002-05-1527

Published: 2002

NARROW

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

Donor Lymphocyte Infusion for Primary Cutaneous T Cell Lymphomas: A Study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the French Study Group on Cutaneous Lymphomas (GFLEC)

Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study

Prospective Phase II Study of Prophylactic Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

Pretransplant Plasmatic Citrulline and Monocyte-Derived Macrophage Reactivity : Two Useful Surrogate Markers to Predict Acute GvHD

Plasma Citrulline Level As a Biochemical Marker to Predict and Diagnose Graft-Versus-Host Disease

Ileostomy As a Treatment Option in Patients with Refractory Acute Gastro-Intestinal Graft Versus Host Disease

Monitoring of Wilms’ Tumor 1 Expression As Minimal Residual Disease in Patients with Acute Myeloid Leukemia to Predict Relapse before and after Allogeneic Stem Cell Transplantation

Long-Term Follow-Up Of Invasive Aspergillosis In Allogeneic Stem Cell Transplantation Recipients and Leukemia Patients: Differences In Risk Factors and Outcoumes

Allogeneic Stem Cell Transplantation From Unrelated One-Antigen HLA-Mismatched Donor, Increases Acute II-IV Gvhd Incidence without Interfering with Other Post-Transplant Complications

Nilotinib as Salvage Therapy In Patients with Chronic Graft Versus Host Disease

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease

Improvement of Supportive Care in Patients Undergoing Myeloablative Allogeneic Stem Cell Transplantation Not Only Reduces Transplant-Related Mortality but Also Increases Long-Term Survival

Immune Reconstitution Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: The Impact of Expanding CD28 neg CD8 + T-Cells on Relapse.

Pre-Transplant Bone Status Evaluation in Patients Undergoing Allogeneic Stem Cell Transplantation.

Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease.

Proportions of T-Cell CD8+ Subsets Lacking CD28 Expression at Day 30 after Myeloablative Allogeneic Stem Cell Transplantation Are Predictive for Relapse and Chronic GVHD.

Efficacy of a low dose of thalidomide in advanced multiple myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only